0001363213-15-000053.txt : 20151229 0001363213-15-000053.hdr.sgml : 20151229 20151229121911 ACCESSION NUMBER: 0001363213-15-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151228 FILED AS OF DATE: 20151229 DATE AS OF CHANGE: 20151229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blobel Friedhelm CENTRAL INDEX KEY: 0001363213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 151310740 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-12-28 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 1 0 0 President & CEO Common Stock 2015-12-28 4 M 0 10000.0 2.49 A 214252 D Common Stock 2015-12-28 4 S 0 10000.0 9.1697 D 204252 D Non-Qualified Stock Option (right to buy) 2.49 2015-12-28 4 M 0 10000.0 0.0 D 2016-06-02 Common Stock 10000 549360 D The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2014. Includes 1,000 and 979 shares purchased under the Issuer's Employee Stock Purchase Plan on August 31, 2015 and November 30, 2015, respectively. Granted under the Issuer's 2005 Equity Incentive Plan. Provided the reporting person remains employed by or acting as a consultant to the Company, the option will become exercisable in four equal annual installments on 6/02/07, 6/02/08, 6/02/09 and 6/02/10. /s/ Friedhelm Blobel, Ph.D. 2015-12-28